Dachaigh › Cancer Pancreatic › North Carolina › Durham
Sgrùdaidhean clionaigeach Cancer Pancreatic ann an Durham, NC
Tha 24 sgrùdaidhean airson Cancer Pancreatic a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
A Study of PHN-012 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
A’ fastadhÌre 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
A’ fastadhSgrùdadh amharc
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A’ fastadhÌre 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mìle air falbh
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A’ fastadhÌre 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A’ fastadhÌre 3
- Investigative Site US035, Chapel Hill · 10 mìle air falbh
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A’ fastadhÌre 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
A’ fastadhÌre 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
A’ fastadh
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
A’ fastadhSgrùdadh amharc
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mìle air falbh
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A’ fastadhÌre 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 mìle air falbh
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A’ fastadhÌre 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
A’ fastadhÌre 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A’ fastadhÌre 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A’ fastadhÌre 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
A’ fastadhÌre 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A’ fastadhÌre 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
A’ fastadhÌre 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
A’ fastadhÌre 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Sgrùdaidhean Cancer Pancreatic ann am bailtean eile
- Houston, TX61 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Boston, MA43 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- Los Angeles, CA35 sgrùdaidhean
- St. Louis, MO33 sgrùdaidhean
- Arlington, VA33 sgrùdaidhean
- Baltimore, MD31 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Tampa, FL26 sgrùdaidhean
- San Diego, CA24 sgrùdaidhean
Sgrùdaidhean eile ann an Durham
- Aillse a' bhroilleach64 sgrùdaidhean
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.